The store will not work correctly when cookies are disabled.
3-(4-Methoxyphenyl)-5-(3,4-dimethoxyphenyl)-1H-pyrrolo[2,3-b]pyridine
ID: ALA3102945
PubChem CID: 59699896
Max Phase: Preclinical
Molecular Formula: C22H20N2O3
Molecular Weight: 360.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2c[nH]c3ncc(-c4ccc(OC)c(OC)c4)cc23)cc1
Standard InChI: InChI=1S/C22H20N2O3/c1-25-17-7-4-14(5-8-17)19-13-24-22-18(19)10-16(12-23-22)15-6-9-20(26-2)21(11-15)27-3/h4-13H,1-3H3,(H,23,24)
Standard InChI Key: PWZJUYIUSIUYGS-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
23.2859 -21.4414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2847 -22.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9995 -22.6817 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.9977 -21.0286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5713 -21.0291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7131 -21.4378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7133 -22.2689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5038 -22.5254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9921 -21.8529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5034 -21.1808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8913 -20.4535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7165 -20.4286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1048 -19.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6685 -19.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8398 -19.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4553 -19.7582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5746 -20.2031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8608 -19.7909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1454 -20.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1483 -21.0329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8626 -21.4414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4304 -19.7922 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4291 -18.9672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0558 -18.2720 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.8803 -18.2432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4354 -21.4481 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7194 -21.0383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 5 1 0
19 22 1 0
22 23 1 0
14 24 1 0
24 25 1 0
20 26 1 0
26 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 360.41 | Molecular Weight (Monoisotopic): 360.1474 | AlogP: 4.92 | #Rotatable Bonds: 5 |
Polar Surface Area: 56.37 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.97 | CX LogP: 4.04 | CX LogD: 4.04 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.55 | Np Likeness Score: -0.30 |
References
1. Gourdain S, Dairou J, Denhez C, Bui LC, Rodrigues-Lima F, Janel N, Delabar JM, Cariou K, Dodd RH.. (2013) Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity., 56 (23): [PMID:24188002] [10.1021/jm401049v] |